The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 21, 2015

Filed:

Apr. 27, 2012
Applicants:

Edward Norbert Van Den Brink, Halfweg, NL;

Cornelis Adriaan DE Kruif, De Bilt, NL;

Mark Throsby, Utrecht, NL;

Inventors:

Edward Norbert Van Den Brink, Halfweg, NL;

Cornelis Adriaan De Kruif, De Bilt, NL;

Mark Throsby, Utrecht, NL;

Assignee:

Crucell Holland B.V., Leiden, NL;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 39/00 (2006.01); A61K 39/42 (2006.01); C07K 16/10 (2006.01); A61K 47/48 (2006.01);
U.S. Cl.
CPC ...
C07K 16/1018 (2013.01); A61K 47/4853 (2013.01); C07K 2317/33 (2013.01); C12N 2760/16111 (2013.01); C12N 2760/16061 (2013.01); C07K 2317/76 (2013.01); C12N 2760/16011 (2013.01); C12N 2760/00011 (2013.01); C12N 2760/00061 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/34 (2013.01); C07K 2317/565 (2013.01); C07K 2317/622 (2013.01); C07K 2317/92 (2013.01);
Abstract

Described are binding molecules such as human monoclonal antibodies that bind to influenza virus H5N1 and have neutralizing activity against influenza virus H5N1. Also described are nucleic acid molecules encoding the antibodies, and compositions comprising the antibodies and methods of identifying or producing the antibodies. The antibodies can be used in the diagnosis, prophylaxis, and/or treatment of an influenza virus H5N1 infection. In certain embodiments, the antibodies provide cross-subtype protection in vivo, such that infections with H5, H2, H6, H9, and H1-based influenza subtypes can be prevented and/or treated.


Find Patent Forward Citations

Loading…